Literature DB >> 18489863

Prediction of mortality in patients with heart failure and systolic dysfunction.

Wayne C Levy1, David T Linker.   

Abstract

Systolic heart failure has a highly variable mortality that can be altered with medications and cardiac devices. This review focuses on recently published predictive models in heart failure. These models may help with difficult decisions such as listing for cardiac transplantation, selecting cardiac devices, and making end-of-life decisions. We discuss systolic heart failure risk models to estimate short- (30-day to 1-year) and longer-term (1- to 5-year) mortality in hospitalized and ambulatory heart failure patients.

Entities:  

Mesh:

Year:  2008        PMID: 18489863     DOI: 10.1007/s11886-008-0034-0

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  49 in total

1.  The mortality effect of metoprolol CR/XL in patients with heart failure: results of the MERIT-HF Trial.

Authors:  S Goldstein; A Hjalmarson
Journal:  Clin Cardiol       Date:  1999-10       Impact factor: 2.882

2.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

3.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators.

Authors:  L T Cooper; G J Berry; R Shabetai
Journal:  N Engl J Med       Date:  1997-06-26       Impact factor: 91.245

4.  Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

Authors:  A Deswal; N J Petersen; A M Feldman; J B Young; B G White; D L Mann
Journal:  Circulation       Date:  2001-04-24       Impact factor: 29.690

5.  Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.

Authors:  Stefan D Anker; Wolfram Doehner; Mathias Rauchhaus; Rakesh Sharma; Darrel Francis; Christoph Knosalla; Constantinos H Davos; Mariantonietta Cicoira; Waqar Shamim; Michel Kemp; Robert Segal; Karl Josef Osterziel; Francisco Leyva; Roland Hetzer; Piotr Ponikowski; Andrew J S Coats
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

6.  Validation of a risk score for dying within 1 year of an admission for heart failure.

Authors:  Thomas S Rector; Sumit N Ringwala; Sudip N Ringwala; Inder S Anand
Journal:  J Card Fail       Date:  2006-05       Impact factor: 5.712

7.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

8.  Comparison of four clinical prediction rules for estimating risk in heart failure.

Authors:  Thomas E Auble; Margaret Hsieh; Julie B McCausland; Donald M Yealy
Journal:  Ann Emerg Med       Date:  2007-04-20       Impact factor: 5.721

9.  Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients.

Authors:  Roman Pfister; Holger Diedrichs; Anne Schiedermair; Stephan Rosenkranz; Martin Hellmich; Erland Erdmann; Christian Alfons Schneider
Journal:  Eur J Heart Fail       Date:  2008-03-04       Impact factor: 15.534

10.  The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT.

Authors:  Roberto Latini; Serge Masson; Inder Anand; Monica Salio; Allen Hester; Dianne Judd; Simona Barlera; Aldo P Maggioni; Gianni Tognoni; Jay N Cohn
Journal:  Eur Heart J       Date:  2004-02       Impact factor: 29.983

View more
  3 in total

1.  Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.

Authors:  Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Susan G Silva; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Wendy Gattis Stough; Rebekka M Arias; Sarah K Rivelli; Ranga Krishnan
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

2.  Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.

Authors:  Christopher M O'Connor; David J Whellan; Daniel Wojdyla; Eric Leifer; Robert M Clare; Stephen J Ellis; Lawrence J Fine; Jerome L Fleg; Faiez Zannad; Steven J Keteyian; Dalane W Kitzman; William E Kraus; David Rendall; Ileana L Piña; Lawton S Cooper; Mona Fiuzat; Kerry L Lee
Journal:  Circ Heart Fail       Date:  2011-11-23       Impact factor: 8.790

3.  Association between neutrophilic granulocyte percentage and depression in hospitalized patients with heart failure.

Authors:  Shuo Pan; Zhong-Wei Liu; Ying Lv; Wen-Qian Song; Xun Ma; Gong-Chang Guan; Yong Zhang; Shun-Ming Zhu; Fu-Qiang Liu; Bo Liu; Zhi-Guo Tang; Jun-Kui Wang
Journal:  BMC Psychiatry       Date:  2016-12-13       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.